Find a Clinical Trial

Neuroblastoma Clinical Trials

Protocol Number	Title
2001CG051	ANBL0032 Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High-Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
2006CG033	COG ADVL0413: A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772, IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias
2007CG010	COG ADVL0612: A Phase I Study of Sunitinib, an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors
2007IS117	Amgen 20050252: A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors
2008CG030	ANBL0531 Response-and Biology-based Therapy for Intermediate-risk Neuroblastoma
2008CG069	COG ADVL0714 "A Phase I Study of VEGF Trap (NSC# 724770, IND #100137) in Children with Refractory Solid Tumors"
2008NTCG101	COG ANBL00B1 "Neuroblastoma Biology Studies"

7 trials displayed